Video: Lyn Wiesinger of Swedish Orphan Biovitrum on profiling a #RareDisease therapeutic company

Lyn Wiesinger of Swedish Orphan Biovitrum on rare disease and orphan drugs Lyn Wiesinger, Commercial Director, North America at Swedish Orphan Biovitrum, presented at last year's World Orphan Drug Congress USA on the topic ‘Swedish Orphan Biovitrum: Profile of a rare disease therapeutic company.'

Do you want to learn more about:

  • Product access in rare diseases
  • Commercial challenges and solutions
  • Professional and patient education in rare diseases

If so, you need to check out the video below:

For more information on orphan drugs and rare diseases, check out the World Orphan Drug Congress USA. Remember, the earlier you book, the more you save, so register now to secure your seat!

Leave a Reply

Your email address will not be published. Required fields are marked *